470
Views
2
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for the treatment of moderately to severely active ulcerative colitis: review of phase II and III clinical trials

, & ORCID Icon
Pages 27-42 | Received 30 Sep 2022, Accepted 27 Feb 2023, Published online: 07 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Turki AlAmeel, Abdulelah AlMutairdi & Badr Al-Bawardy. (2023) Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials. Clinical and Experimental Gastroenterology 16, pages 147-167.
Read now
Silvia Salvatori, Benedetto Neri, Irene Marafini, Mattia Brigida & Giovanni Monteleone. (2023) Emerging oral drug options for ulcerative colitis. Expert Opinion on Emerging Drugs 0:0, pages 1-11.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.